Onychomycosis Market Size Expected to Witness Significant Growth by 2034, estimates DelveInsight

Emerging Onychomycosis therapies including BB2603 (Blueberry Therapeutics), VT-1161 (Mycovia Pharmaceuticals), KERYDIN (tavaborole), JUBLIA/CLENAFIN (efinaconazole), and others are driving market size. DelveInsight's "Onychomycosis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Onychomycosis, historical and forecasted epidemiology,